Aidoc, founded in 2016 by Elad Walach, Michael Braginsky, and Guy Reiner in Tel Aviv, builds clinical AI that scans radiology images for critical findings and flags them for faster review, aiming to catch time-sensitive conditions earlier in a radiologist's queue rather than waiting for a routine read.
The FDA cleared Aidoc's comprehensive AI triage solution covering 11 newly cleared indications alongside 3 previously cleared ones in a single workflow, with the pivotal study showing a mean sensitivity of 97% and mean specificity of 98% across those findings, and in 2026 the company earned a second FDA Breakthrough Device Designation for First Read, an AI that drafts preliminary chest radiograph reports. Aidoc has analyzed more than 120 million patient cases across nearly 2,000 hospitals worldwide, backed by a $150 million Series E in April 2026 led by Goldman Sachs with Nvidia's venture arm participating, bringing total funding past $500 million.
Enterprise pricing is negotiated per hospital and requires a sales conversation. For a radiology department that wants time-sensitive findings flagged and triaged automatically across a broad range of conditions, rather than a single-condition detection tool, Aidoc's comprehensive triage coverage addresses that directly.
